GRN and neoplasm: To test the hypothesis of whether CLL is driven by intracellular GRN within CLL cells, GRN-deficiency of tumor cells needs to be achieved, for example by crossing transgenic Eμ-TCL1 with Grn−/− mice, or by disrupting GRN in human CLL cells in vitro.